EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
about
Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the communityAdrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the communityGuidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panelA comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference.H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review.Anaphylaxis: mechanisms and management.Anaphylaxis in children: current understanding and key issues in diagnosis and treatment.Anaphylaxis treatment: current barriers to adrenaline auto-injector use.Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.CSACI position statement: epinephrine auto-injectors and children < 15 kg.Management of food allergies.Acute treatment of anaphylaxis in childrenManagement of anaphylaxis in the emergency setting.Mastocytosis: update on pharmacotherapy and future directions.Assessment of self-administered epinephrine during a training session.Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use.Emergency management of anaphylaxis: current pharmacotherapy and future directions.
P2860
Q24201463-2DB469A3-6FE9-443F-BCD8-550E59884951Q24235431-4DC6C0F1-0574-4D79-9238-31DD3C050E0CQ28300001-C407F658-7DD5-4000-9650-381C104C592FQ30435783-99E95496-7290-4BFB-ACF6-A6D6E7984C6BQ33290329-F81ECB2A-0E5E-4BBB-BFD8-6ED9A43B9EB0Q34192100-756FD186-7944-48EA-8483-B5D2472D3BBAQ34289198-A58EF89C-AD3B-4003-864A-FF2648B5A361Q34420331-3A5A0844-3F22-4711-A472-50EF98F89C40Q34423618-2002F879-0E43-4DED-BD68-E9491751B2AAQ34483043-5114E007-2412-48D9-9E24-516C11F5A5B5Q34534941-374080E1-CB22-4B37-B24B-535DE80F1FCBQ37008122-E8989B43-EC59-45DC-9D4F-97E628BAEA24Q37729047-99FFA1E2-284A-40B4-93D8-42B69A4979C0Q38138597-B720F684-2422-4DAF-9BAD-FA1894CF7365Q48132704-ABA4B0E3-A771-447C-AAD2-A50806584F23Q50034090-E79AA044-3EE3-4CCE-A839-850C6B392C65Q51473822-6CA3A922-BB01-4EDF-A6D4-8098A132923B
P2860
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
@en
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
@nl
type
label
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
@en
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
@nl
prefLabel
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
@en
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
@nl
P2093
P356
P1476
EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
@en
P2093
F Estelle R Simons
Keith J Simons
Norman A Silver
Xiaochen Gu
P304
P356
10.1067/MAI.2002.120758
P407
P577
2002-01-01T00:00:00Z